Asset
TESEVATINIB
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00704392 | phase1 | withdrawn | 2008-06-01 | 2009-12-01 | Exelixis | Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors |
FDA applications (0)
This company has no applications containing this asset.